Beta. We may invite You to try beta versions of the Cloud Service. You may need to agree to additional terms for the beta Cloud Service. A beta Cloud Service is provided for evaluation and feedback purposes and may not be used in a production environment. You understand that a beta Cloud Service is not generally released and, therefore, is unsupported and may contain bugs, errors, and other issues. You accept the beta Cloud Service “AS-IS,” without warranty of any kind, and Cisco is not responsible for any problems or issues related to Your use of the beta Cloud Service. The beta Cloud Service may never be generally available and we may discontinue the beta Cloud Service in our sole discretion at any time for any reason and delete any Customer Data or data on the beta Cloud Service without liability to You.
Beta. Some NetBrain products may be available to Customer as a preview, or as an alpha, beta, or other pre-release version (each, a “Beta Offering”). Such Beta Offering is solely for Customer’s internal testing and evaluation on its production or non-production environment. Customer’s use of a Beta Offering will be for the term specified by NetBrain in an Order, or, if earlier, when that version of the Beta Offering becomes generally available. NetBrain may discontinue the Beta Offering at any time and may decide not to make any of the features and functionality generally available.
Beta. Almost final version of the License Product(s) that is a fully functional, nearly bug-free disk that incorporates finalized art and game play.
Beta. Supplier will set up a Beta instance of the Service Pages for PFM 10.x. The Beta website will be accessible from the Service Pages as a place to showcase new feature / functionality, but will not be used by Registered Users as part of their use of the Hosted Service. The Beta website will be maintained and operated by Supplier in consultation with the Bank of America. However, the Beta website is not subject to standard SLAs defined elsewhere in the contract. Bank of America will control the access of the beta site for their end users. For avoidance of doubt, the Cut-Over Date will not be deemed to have occurred until PFM 10.x is operating in full production for the Registered Users of the Bank of America. Consumer/Small Business Division on a non-Beta site.
Beta. Upon acceptance of the Beta version of the PDFPress Client Software and PDFPress Server Software under Section 5.2, Adobe shall pay to ESPS three hundred thousand dollars ($300,000) as a refundable pre- payment of the License Fee.
Beta. Inserted Ce Inserted Ce Inserted Ce
Beta. Provider will make the Web Service available to Customer, in beta format, for review and approval either
(i) by means of password access to a non-public server where the Web Service is displayed for Customer or (ii) by emailing the html page containing presentation of the Web Service to Customer for approval. If Customer does not provide the Customer Collateral in a timely manner upon request from Provider, then Provider shall not be responsible for, and Customer shall excuse in full, any delay in the deliver of the Web Service hereunder.
Beta. We may invite you to try beta versions of the SaaS. You may need to agree to additional terms for the beta SaaS. Beta SaaS is provided for evaluation and feedback purposes and may not be used in a production environment. You understand that beta SaaS is not generally released and, therefore, is unsupported and may contain bugs, errors and other issues. You accept the beta SaaS “AS-IS,” without warranty of any kind, and Cisco is not responsible for any problems or issues related to your use of the beta SaaS. The beta SaaS may never be generally available and we may discontinue beta SaaS in our sole discretion at any time and delete any Content or data on the beta SaaS without liability to you. Trial: We may give you trial access to SaaS, which also may be subject to additional terms. Any trial period will expire on the later of 30 days or as otherwise stated in writing from Cisco. Trial SaaS also is provided “AS- IS” without support or any express or implied warranty of any kind.
Beta. There was a significant increase in beta amplitude following ∆9-THC which was seen in both the placebo and CBD group. ∆9-THC also increased beta amplitude differently according to scalp location, where the increase was greatest at temporal regions. The finding that beta was increased by ∆9-THC is contrary to previous ∆9-THC studies where generally ∆9-THC has been found to reduce beta (Xxxx et al., 2004, 2005; Xxxx et al., 2010; Xxxxxxxx et al., 2011). However, Xxxxxx and colleagues observed an increase in beta for the doses of 29mg and 49mg, while the 69mg dose produced a drop in beta power (Koen B E Böcker et al., 2010). Beta activity is commonly considered to be related to states of alertness, activity and possibly even anxiety. One study found that decreased beta activity was related to feeling more relaxed (Xxxxxxxxxx et al., 2008). The disparity between the results of this study with past findings may be explained by the higher dose and intravenous administration of ∆9-THC which might have made participants feel more anxious or alert compared to previous studies. Furthermore, CBD did not change beta amplitude or affect ∆9-THC-induced beta increase. An alternative explanation may also be that ∆9-THC made participants clench their jaws more and increasing beta amplitude, particularly since the greatest increase was seen in temporal locations. Similar to beta, gamma amplitude was also significantly increased following ∆9-THC, with no protective effects of CBD. This is in line with previous intravenous ∆9-THC studies in humans (Xxxxxxxx et al., 2011), although animal studies have consistently shown reductions to gamma in the hippocampus (Xxxxx et al., 2008; Xxxxx et al., 2000; Xxxxxxxx et al., 2011). These discrepancies may be explained by the use of the more potent CB1 agonists CP55940 which is roughly 45 times as potent as ∆9-THC (Xxxxxxx- Xxxxxxx et al., 1996), but also that the recoding electrodes were implanted directly onto the hippocampus as opposed to mere scalp recordings. Furthermore, scalp gamma recordings are vulnerable to a significant amount of artefacts from tonic muscle activity, which can be minimised using modern artefact reduction techniques (Xxxxxxx et al., 2013). Since the main focus of this study is the effects of cannabinoids on the lower frequency bands such artefact reductions were not performed, which limits the reliability of the findings. Also, similar to beta amplitude gamma may also have increased as a result of increased mus...
Beta a. The Software/client/service includes all the functionality required to meet the release goals. Licensees are actively testing the software and submitting bugs. [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
b. Danger provides the following:
i. Danger forms an external test group.
ii. Upgrades are made available for download.
iii. Release notes for each build are posted.
